Searched for
GRAND PHARMACEUTICAL
Chinese business hired lobbying firm with ties to Donald Trump Jr, then scored a win in WashingtonA U.S. startup's bid to remove a Chinese investor from its board was rejected by a national security watchdog. A lobbying firm connected to...- INOX Air Products plans $1 billion IPO, appoints bankers, sources sayINOX Air Products, a joint venture between American Air Products and Chemicals and India's INOX Group, is gearing up for a significant $1 b...
- Indian gas maker INOX Air Products plans $1 billion IPO, appoints bankers, sources sayIndian industrial and medical gas maker INOX Air Products is planning to launch a $1 billion initial public offering in Mumbai, and has app...
- Who are Netra Mandena and Vamsi Gadiraju? Inside the star-studded Udaipur wedding attended by Jennifer Lopez, Trump Jr and Justin BieberNetra Mandena, daughter of US-based billionaire Rama Raju Mantena, is marrying tech co-founder Vamsi Gadiraju in a lavish Udaipur wedding. ...
- Who is Raj Ramalinga Mantena, whose daughter’s Udaipur wedding will be attended by Trump, JLo and Hrithik Roshan?Udaipur is gearing up for one of 2025’s most extravagant weddings, hosted by pharma tycoon Raj Mantena. With global VIPs, Bollywood stars, ...
- Glenmark’s nasal spray Ryaltris gets China’s NMPA nod for allergic rhinitis; to be commercialised by Grand PharmaRyaltris is a fixed-dose combination of olopatadine, an antihistamine and mometasone furoate, a corticosteroid to treat the symptoms of all...
- US to impose 100% tariff on branded, patented drugs unless made domestically, Trump warns tariffs could rise to 250%Donald Trump announced new tariffs. The US will impose a 100 per cent tariff on specific pharmaceutical products from October 1. There is a...
- Stock market update: Nifty Pharma index advances 0.36% in an upbeat marketThe Nifty Pharma index was trading 0.36 per cent up at 22186.4.
- President Droupadi Murmu conferred with Timor-Leste's highest civilian honourPresident Droupadi Murmu made a historic visit to Timor-Leste, marking the first-ever presidential visit from India to the Asian country. S...
- Mumbai or London or Abu Dhabi? Anant Ambani-Radhika Merchant's wedding venue of remains a mysteryThe Ambanis hosted an extravagant pre-wedding celebration for Anant and Radhika, spanning three opulent days. The guest list included lumin...
- Glenmark bets on respiratory drug, licensing deals to improve businessGlenmark had gross debt of ₹3,765 crore as of June 30, 2022. The company over the years accumulated debt to fund its innovation-led R&D and...
- Glenmark Pharma inks exclusive licensing agreement with Lotus InternationalGlenmark will receive an upfront payment as well as regulatory and sales-based milestone payments from Lotus, it added.
- Glenmark gets marketing approval for Ryaltris in 13 EU, UK countriesSales of the nasal spray continue to progress well in Australia, South Africa, Ukraine and Uzbekistan, it said adding the company has also ...
- US charges Teva Pharmaceutical Industries Ltd in generic drugs price-fixing probeThe Justice Department has been investigating allegations the company colluded with other drugmakers to push up the prices of widely used p...
- Can pharma learn from auto? Of course!The drug industry is facing threats from unexpected rivals such as Google and Samsung, while the auto sector is grappling with new-age neme...
- Sun Pharma tanks even as net profit doubles in Q4India sales of the pharma firm jumped 17 per cent to Rs 1,807 crore whereas US finished dosage sales rose 19 per cent YoY to $580 million i...
- Sun Pharmaceuticals summoned by US Department of JusticeCompany did not elaborate on the summons but such a grand subpoena by the DoJ anti-trust division is usually issued to check anti-competiti...
- Monaco invites Indian firms to invest in IT, pharma sectorsMonaco government invited Indian companies to invest in various sectors, including information and technology, pharmaceuticals and realty.
- Taro Pharma shareholder rejects Sun Pharma's revised offerA minority shareholder of Taro Pharma on Monday rejected Sun Pharma's sweetened offer price of $39.5 a share for a buyout, signalling furth...
- Guardian Point asks Sun Pharma to up Taro Pharma offerGuardian Point Capital, one of the minority shareholders of Israeli firm Taro Pharma, has asked Sun Pharma to revise $24.50 share price off...
Load More
